ProPhase Labs, Inc. Commitments and Contingencies
ProPhase Labs, Inc. (PRPH) had Commitments and Contingencies of $0 as of 2014-06-30, per its 10-Q filed 2014-08-12.
Discontinued › Balance Sheet › Liabilities
us-gaap:CommitmentsAndContingencies · last filed 2014-08-12
- 2014-06-30: Commitments and Contingencies $0.00.
- 2013-12-31: Commitments and Contingencies $0.00.
- 2013-03-31: Commitments and Contingencies $0.00.
- 2012-12-31: Commitments and Contingencies $0.00.
| Period end | Commitments and Contingencies |
|---|---|
| 2014-06-30 | $0.00 10-Q · filed 2014-08-12 |
| 2013-12-31 | $0.00 10-Q · filed 2014-08-12 |
| 2013-03-31 | $0.00 10-Q · filed 2013-05-10 |
| 2012-12-31 | $0.00 10-Q · filed 2013-05-10 |
| 2012-09-30 | $0.00 10-Q · filed 2012-11-14 |
| 2012-06-30 | $0.00 10-Q · filed 2012-08-13 |
| 2011-12-31 | $0.00 10-K · filed 2013-03-28 |
| 2011-06-30 | $0.00 10-Q · filed 2011-08-12 |
| 2010-12-31 | $0.00 10-K · filed 2012-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |